title: PML in a patient treated with fumaric acid.
authors.forename: Ummehan
authors.initials: U
authors.lastname: Ermis
authors.forename: Joachim
authors.initials: J
authors.lastname: Weis
authors.forename: Jörg B
authors.initials: JB
authors.lastname: Schulz
mesh_terms: D000368:Aged; D001921:Brain / Q000473:pathology; D003879:Dermatologic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005650:Fumarates / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000209:etiology; D007153:Immunologic Deficiency Syndromes / Q000139:chemically induced*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced*; D008297:Male; D011565:Psoriasis / Q000188:drug therapy
chemical_list: D003879:Dermatologic Agents; D005650:Fumarates; C032005:fumaric acid